Product Description
Overall, the global tissue heart valve market was valued at $1.55 billion in 2023. This is expected to increase over the forecast period at a CAGR of 0.1% to reach $1.56 billion.
The full report suite on the global market for tissue heart valve includes stented, stentless and sutureless tissue heart valves. Edwards Lifesciences, Medtronic, and Abbott were the top three market share leaders in the global tissue heart valve market.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2030, and Historical Data to 2020
- Recent Mergers & Acquisitions
- Disease Overviews
- Company Profiles, Product Portfolios, and SWOT for Top Competitors
GLOBAL TISSUE HEART VALVE MARKET INSIGHTS
The market for tissue heart valves is increasingly being supported by the rise in popularity of sutureless and stentless models. These alternatives have demonstrated faster recovery times and fewer complications across various device models, as recent clinical evidence indicates. As such, the decline in the use of stented heart valves is a trend likely to persist throughout the forecast period, further driven by advancements in transcatheter aortic valve replacement (TAVR) and other minimally invasive procedures.
GLOBAL TISSUE HEART VALVE MARKET SHARE INSIGHTS
Edwards Lifesciences leads the tissue heart valve market with its Carpentier-Edwards® surgical valves and PERIMOUNT® aortic products. Thanks to its global reach and established offerings, Edwards is poised to maintain its market dominance.
Medtronic, ranking second, offers Hancock™, Mosaic™, Avalus™, and other valves primarily used for aortic and mitral replacements. With its exit from the ventricular assist device sector, Medtronic is expected to enhance its footprint in the heart valve market.
Abbott, the third key player, provides the Epic™ mitral valve and Trifecta™ aortic valve. Despite a competitive market, Abbott is unlikely to increase its market share significantly in the coming period.
MARKET SEGMENTATION SUMMARY
Markets Included:
- Stented Tissue Heart Valve Market
- Stentless Tissue Heart Valve Market
- Sutureless Tissue Heart Valve Market
Procedures Included:
- Surgical Heart Valve Replacement – Segmented by:
- Valve type: aortic, mitral, tricuspid, pulmonary
RESEARCH SCOPE SUMMARY
Report Attribute | Details |
---|---|
Regions | North America(Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East(Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Mongolia, Malaysia, Myanmar, New Zealand, Philippines, Pakistan, Singapore, South Korea, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2023 |
Forecast | 2024-2030 |
Historical Data | 2020-2023 |
Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |